FDA Clears Medacta’s 3DMetal Tibial Cones for Knee Revision

Family-owned orthopedics developer Medacta International announced the first surgeries utilizing its recently FDA-cleared 3DMetal Tibial Cones for knee revision surgery. The 3DMetal Tibial Cones can be used for structural support in areas of bone deficiencies that may compromise revision implant fixation, and are indicated for use with Medacta’s GMK Revision and GMK Hinge Knee systems, as well as the GMK tibial extension stems and offset. The first surgeries utilizing this technology were performed by Kevin Hardt, M.D., and David Manning, M.D., of the Northwestern University Feinberg School of Medicine in Chicago, Ill. and Dragan Jeremic, M.D., of St. Vincenz Krankenhaus Brakel in Brakel, Germany.
 
“Medacta’s 3DMetal Tibial Cones recreate a proximal structural foundation for the intended revision implant by achieving proximal fixation and force transmission in the remaining host bone,” said Dr. Manning, a revision knee specialist and designer of the 3DMetal Tibial Cones. Dr. Hardt added: “The instrumentation was straightforward to use and complementary to my typical revision workflow. I was impressed with the surgical press fit of the implant.”
 
A Medacta innovation, 3DMetal is a three-dimensional advanced biomaterial based on 3D printing technology that enables direct structural and functional connection with the bone through an interconnecting pore structure similar to the cancellous bone structure. With this new solution, the Medacta knee portfolio allows surgeons to address multiple revision scenarios, including even the most challenging of cases.
 
Dr. Jeremic, also an expert in primary and revision total knee replacement, commented: “I am very satisfied with this new implant and the result. From now on, this will be an excellent option for my patients.”
 
“It is Medacta’s mission to be a partner for our surgeons, even in the most challenging scenarios,” said Francesco Siccardi, executive vice president of Medacta International. “With our innovative 3DMetal technology, we have extended the range of advanced solutions for our surgeons and we will continue to do so in the future.”
 
Medacta will launch the 3DMetal Tibial Cones for the U.S. market at the American Academy of Orthopaedic Surgeons Annual Meeting, which will be held in New Orleans in March 2018. The Medacta Shoulder System, announced earlier this month, will also be introduced at the meeting.